Concluding Discussion

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Dr. H. Meltzer: Readers of this Supplement should find answers to questions such as: How should various stakeholders evaluate cost effectiveness? Is cost-utility analysis an accepted form of research? Why should managed care companies or government agencies be interested in pharmacoeconomic analysis?​

J Clin Psychiatry 1999;60(suppl 3):59-60